Time and dose-dependent effect of systemic glucocorticoids on major adverse cardiovascular event in patients with rheumatoid arthritis: a population-based study.
Ho SoTsz On LamHuan MengSteven Ho Man LamLai Shan TamPublished in: Annals of the rheumatic diseases (2023)
GC was associated with a duration and dose-dependent increased risk of MACE in patients with RA. Very low dose prednisolone (<5 mg daily) did not appear to confer excessive CV risk.